Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/12/2002 | EP1212075A1 Peptides capable of modulating the function of cd66 (ceacam) family members |
06/12/2002 | EP1212074A1 Hybrid peptides modulate the immune response |
06/12/2002 | EP1212066A1 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
06/12/2002 | EP1211933A1 Pa28 modified transgenic mice |
06/12/2002 | EP1211931A1 A knockout mouse for the tumor suppressor gene anx7 |
06/12/2002 | EP1084227A4 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
06/12/2002 | EP1056474B1 Affinity markers for human serum albumin |
06/12/2002 | EP1039922B1 Improved interferon polymer conjugates |
06/12/2002 | EP0822941B1 Monoclonal antibodies against hiv-1 and vaccines made thereof |
06/12/2002 | EP0802800B1 Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules |
06/12/2002 | EP0777677B1 Methods of identifying compounds useful for treating autoimmune diseases |
06/12/2002 | EP0759774B1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic |
06/12/2002 | EP0749325B1 Bispecific molecules having clinical utilities |
06/12/2002 | EP0749317B1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
06/12/2002 | EP0741576B1 Co-administration of interleukin-3 mutants with colony stimulating factors |
06/12/2002 | EP0734391B1 Pna-dna-pna chimeric macromolecules |
06/12/2002 | EP0722452B1 Nf-at polypeptides and polynucleotides |
06/12/2002 | EP0669833B1 Type ii tgf-beta-binding receptor fragment as therapeutic agent |
06/12/2002 | EP0574395B1 Cytokine immunoconjugates |
06/12/2002 | EP0433372B1 Oral immunization by transgenic plants |
06/12/2002 | CN1353764A Method for selecting improved vectors |
06/12/2002 | CN1353762A Pectate lyase fusion for expression and secretion of polypeptides |
06/12/2002 | CN1353761A Preparation of biologically active molecules |
06/12/2002 | CN1353756A Compositions and method for the modification of gene expression |
06/12/2002 | CN1353755A Method of removing N-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |
06/12/2002 | CN1353753A Oligouncleotide for detection and identification of mycobacteria |
06/12/2002 | CN1353678A Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
06/12/2002 | CN1353614A Method of treating chronic cardiac disease |
06/12/2002 | CN1353187A Vegetable lectin gene |
06/12/2002 | CN1353115A Synthesis and expression of recombinant human parathyroxin gene |
06/12/2002 | CN1353114A Human papillomavirus 11L1-E7 recombination protein and its application |
06/11/2002 | USRE37741 Purified nontypable Haemophilus influenzae P5 protein as a vaccine for nontypable Haemophilus influenzae infection |
06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
06/11/2002 | US6403957 Nucleic acid reading and analysis system |
06/11/2002 | US6403865 Fertile transgenic maize plant comprising foreign dna sequence encoding bacillus thuringiensis insecticidal protein toxic to european corn borer stably incorporated into genome which expresses protein in leaf tissue causing mortality to borer |
06/11/2002 | US6403864 Precursor polypeptide of a plant growth factor, a gene encoding a precursor polypeptide of a plant growth factor and a method for promotion of plant growth |
06/11/2002 | US6403862 Isolated promoter capable of driving transcription in seed-preferred manner which comprises polynucleotide having specified sequence |
06/11/2002 | US6403860 Ku80 homologue and uses thereof |
06/11/2002 | US6403785 Isolated DNA molecule encoding human TSC403 |
06/11/2002 | US6403784 Human uncoupling proteins and polynucleotides encoding the same |
06/11/2002 | US6403783 Isolated nucleic molecule encoding new polypeptide having diagnostic and therapeutic uses |
06/11/2002 | US6403782 Nucleic acid encoding eotaxin |
06/11/2002 | US6403780 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
06/11/2002 | US6403771 Loading onto binding medium relatively long lived radioisotope, decay sequence yielding daughter isotopes that emit predominantly alpha-and/or beta-particles, eluting alpha-particle emitting isotope, coupling to targeting moiety |
06/11/2002 | US6403770 Antibodies to neutrokine-alpha |
06/11/2002 | US6403769 Fusion protein having nonantibody portion comprised of effector domain from growth factor or growth factor receptor joined to aminoterminal end of immunoglobulin g-derived sequence which lacks ch1 domain |
06/11/2002 | US6403768 Manipulation of Mlo genes to enhance disease resistance in plants |
06/11/2002 | US6403767 Polypeptide molecules of the G protein-coupled heptahelical receptor superfamily and uses therefor |
06/11/2002 | US6403766 Isolated human actin-binding regulatory protein expressed in motile, proliferating and invasive cells and in cells at wound sites |
06/11/2002 | US6403765 Truncated Apaf-1 and methods of use thereof |
06/11/2002 | US6403764 Variant wherein amino acid residue at position 16 of native-sequence human igf-1 is replaced with glycine or serine, or amino acid residue at position 25 or 49 or residues at 3 and 49 are replaced with alanine, glycine, or serine |
06/11/2002 | US6403763 Chiral peptide nucleic acids which hybridize strongly with complementary nucleic acids; antigene and antisense agents; tools in molecular biology |
06/11/2002 | US6403559 C-kit ligand-based method for expanding peripheral blood cell levels |
06/11/2002 | US6403558 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
06/11/2002 | US6403557 Fibroblast growth factor-13 |
06/11/2002 | US6403556 Pharmaceutical preparation containing protein C and a thrombolytically active substance |
06/11/2002 | US6403553 Induced by chemotherapy, irradiation, or disease; macrophage inflammatory proteins give significant and specific increase of platelet count |
06/11/2002 | US6403552 Ob receptor and methods for the diagnosis and treatment of body weight disorders |
06/11/2002 | US6403374 Long wavelength engineered fluorescent proteins |
06/11/2002 | US6403373 Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these |
06/11/2002 | US6403372 Aspergillus fumigatus profilin |
06/11/2002 | US6403370 Generation an infection, reproduction, genetic engineering |
06/11/2002 | US6403361 Enzymatic method for modification of recombinant polypeptides |
06/11/2002 | US6403360 Isolated nucleic acids |
06/11/2002 | US6403337 Staphylococcus aureus genes and polypeptides |
06/11/2002 | US6403336 Dna segment encodes protective peptide-fused atriopeptin; microorganisms transformed with vectors; genetic engineering |
06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
06/11/2002 | US6403334 gidB from Staphylococcus aureus |
06/11/2002 | US6403325 Methods and compounds for treating alzheimer's disease |
06/11/2002 | US6403323 Ampa-binding human GluR3 receptors |
06/11/2002 | US6403319 Mixing nucleic acid samples with hairpin primers; incubation, amplification, hybridization, and detection; sequence determination, genetic engineering |
06/11/2002 | US6403318 Fatty acid synthase mRNA binding protein |
06/11/2002 | US6403308 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
06/11/2002 | US6403307 Amplification of genomic dna or mrna or complement; analyzing for mutation |
06/11/2002 | US6403306 Detection and diagnosis of meningococcal strains; vaccines with capsular polysaccharide conjugates; genetic engineering |
06/11/2002 | US6403305 Genetic expression of self-activating fusion protein in cell; testing tethered combinatorial peptide libraries |
06/11/2002 | US6403304 Human osteoclast-specific and -related DNA sequences |
06/11/2002 | US6403299 Transforming non-leflunomide resistant cell with dna sequence encoding deah box protein that binds atp and nucleic acid; culturing; modulating helicase activity; genetic engineering |
06/11/2002 | US6403103 Cytoplasmic protein fragment selected from: the amino acid sequence from residue 402 to residue 426 of seq id no: 2; and an immunogenic fragment of said amino acid sequence comprising at least residue 408 to residue 417 of said amino acid |
06/11/2002 | US6403102 Chlamydia antigens and corresponding DNA fragments and uses thereof |
06/11/2002 | US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof |
06/11/2002 | US6403100 Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated |
06/11/2002 | US6403099 Conjugates formed from heat shock proteins and oligo-or polysaccharides |
06/11/2002 | US6403097 Deletion in the glycoprotein ge-gene |
06/11/2002 | US6403096 Dimer, linked by a disulfide bridge; improves the uptake of therapeutic and diagnostic agents at a tumor site |
06/11/2002 | US6403094 Clostridium perfringens vaccines |
06/11/2002 | US6403093 Methods to detect granulocytic ehrlichiosis |
06/11/2002 | US6403092 Immune response modulator alpha-2 macroglobulin complex |
06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
06/11/2002 | US6403090 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
06/11/2002 | US6403088 Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3) |
06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
06/11/2002 | US6403082 Administering polynucleotide |
06/11/2002 | US6403080 Methods of modulating an immune response to antigen, and cells for use in the method |
06/11/2002 | US6403079 Using polypeptide |
06/11/2002 | US6403077 Treatment regimes featuring an IL-10-containing chimeric polypeptide |
06/11/2002 | US6403076 Polypeptides |
06/11/2002 | US6402913 Separation of plasma components |
06/11/2002 | CA2276614C Analogs of parathyroid hormone |